S A Prigent

1.7k total citations
10 papers, 1.5k citations indexed

About

S A Prigent is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, S A Prigent has authored 10 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in S A Prigent's work include Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). S A Prigent is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). S A Prigent collaborates with scholars based in United Kingdom, United States and France. S A Prigent's co-authors include William J. Gullick, Lewis C. Cantley, Kermit L. Carraway, Stephen P. Soltoff, N R Lemoine, Gregory D. Plowman, WJ Gullick, Clare Selden, Kenneth Siddle and Keith K. Stanley and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Molecular and Cellular Biology.

In The Last Decade

S A Prigent

10 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S A Prigent United Kingdom 10 1.0k 864 644 171 146 10 1.5k
Natalia Sergina United States 9 866 0.9× 681 0.8× 489 0.8× 252 1.5× 150 1.0× 9 1.3k
Magdalena Koziczak Switzerland 8 703 0.7× 786 0.9× 382 0.6× 156 0.9× 114 0.8× 9 1.4k
Kendall D. Carey United States 10 1.1k 1.0× 951 1.1× 651 1.0× 373 2.2× 89 0.6× 12 1.9k
Judit Anido Spain 7 1.3k 1.3× 745 0.9× 588 0.9× 301 1.8× 93 0.6× 14 1.7k
Thinh Q. Pham United States 8 913 0.9× 629 0.7× 411 0.6× 303 1.8× 53 0.4× 10 1.3k
Iwan Beuvink Switzerland 11 840 0.8× 1.1k 1.3× 272 0.4× 204 1.2× 66 0.5× 13 1.7k
Maria Sundvall Finland 20 949 0.9× 1.2k 1.4× 364 0.6× 303 1.8× 96 0.7× 33 1.8k
D Chin United States 15 721 0.7× 605 0.7× 417 0.6× 85 0.5× 78 0.5× 20 1.0k
Rebecca S. Muraoka-Cook United States 14 680 0.7× 888 1.0× 169 0.3× 97 0.6× 100 0.7× 16 1.3k
Dhara N. Amin United States 12 684 0.7× 782 0.9× 284 0.4× 177 1.0× 66 0.5× 19 1.2k

Countries citing papers authored by S A Prigent

Since Specialization
Citations

This map shows the geographic impact of S A Prigent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S A Prigent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S A Prigent more than expected).

Fields of papers citing papers by S A Prigent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S A Prigent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S A Prigent. The network helps show where S A Prigent may publish in the future.

Co-authorship network of co-authors of S A Prigent

This figure shows the co-authorship network connecting the top 25 collaborators of S A Prigent. A scholar is included among the top collaborators of S A Prigent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S A Prigent. S A Prigent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Saraux, Alain, S A Prigent, P. Plantin, et al.. (2008). Cutaneous events during treatment of chronic inflammatory joint disorders with anti‐tumour necrosis factor alpha: a cross‐sectional study. Journal of the European Academy of Dermatology and Venereology. 22(12). 1471–1477. 15 indexed citations
2.
Manson, Margaret M., Karen Holloway, Lynne Howells, et al.. (2000). Modulation of signal-transduction pathways by chemopreventive agents. Biochemical Society Transactions. 28(2). 7–12. 26 indexed citations
3.
Ma, Yunfang, et al.. (1999). Microinjection of anti-p21 antibodies induces senescent Hs68 human fibroblasts to synthesize DNA but not to divide.. PubMed. 59(20). 5341–8. 19 indexed citations
4.
Carraway, Kermit L., et al.. (1994). ErbB3 Is Involved in Activation of Phosphatidylinositol 3-Kinase by Epidermal Growth Factor. Molecular and Cellular Biology. 14(6). 3550–3558. 197 indexed citations
5.
Prigent, S A & William J. Gullick. (1994). Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera.. The EMBO Journal. 13(12). 2831–2841. 316 indexed citations
6.
Soltoff, Stephen P., et al.. (1994). ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.. Molecular and Cellular Biology. 14(6). 3550–3558. 446 indexed citations
7.
Johnson, G R, S A Prigent, W.J. Gullick, & Kurt Stromberg. (1993). Characterization of high and low molecular weight forms of amphiregulin that differ in glycosylation and peptide core length. Evidence that the NH2-terminal region is not critical for bioactivity.. Journal of Biological Chemistry. 268(25). 18835–18843. 29 indexed citations
8.
Lemoine, NR, et al.. (1992). Expression of the ERBB3 gene product in breast cancer. British Journal of Cancer. 66(6). 1116–1121. 203 indexed citations
9.
Prigent, S A, et al.. (1992). Expression of the c-erbB-3 protein in normal human adult and fetal tissues.. PubMed. 7(7). 1273–8. 149 indexed citations
10.
Prigent, S A, Keith K. Stanley, & Kenneth Siddle. (1990). Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies.. Journal of Biological Chemistry. 265(17). 9970–9977. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026